Treatment of Multiorgan Sarcoidosis With Tofacitinib.
William E DamskyBryan D YoungBrett SloanEdward J MillerJ Antonio ObandoBrett KingPublished in: ACR open rheumatology (2020)
This case illustrates the promise of JAK inhibition as a strategy to treat recalcitrant sarcoidosis and suggests that further study of JAK inhibitors in sarcoidosis is needed.